Brief: Hemostemix Announces Appointment Of Experienced Chief Medical Officer & President
01/04/2019 14:40
April 1 (Reuters) - Hemostemix Inc HEM.V :
* HEMOSTEMIX ANNOUNCES APPOINTMENT OF EXPERIENCED CHIEF
MEDICAL
OFFICER & PRESIDENT
* HEMOSTEMIX INC - ALAN J. JACOBS, HAS BEEN APPOINTED
COMPANY'S
PRESIDENT AND CHIEF MEDICAL OFFICER.
* HEMOSTEMIX INC - JACOBS TAKES OVER ROLE OF PRESIDENT FROM
KYLE
MAKOFKA WHO REMAINS AS COMPANY'S CEO
Source text for Eikon: ID:nGNX6pZcLb
Further company coverage: HEM.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hemostemix
See all newsBrief: Hemostemix Announces Financing Update And Secured Convertible Debenture Financing Of Up To $2,000,000
Brief: Aspire Health Science Files Supplemental Motion For Expedited Hearing In Lawsuit Against Hemostemix Inc. And Suspends Patient Recruitment For Hemostemix Cli Phase 2 Clinical Trial
Brief: Aspire Health Sciences Says On Jan 28, 2020, Initiated Legal Proceeding Against Hemostemix Inc
Brief: Hemostemix Announces Private Placement
Brief: Hemostemix Announces Corporate Update